141 related articles for article (PubMed ID: 38112929)
21. [Value of Glasgow prognostic score in patients with adenocarcinoma of esophagogastric junction].
Cui Y; Li J; Liu M; Shi Z; Fu Y; Cai L; Gao T
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jan; 19(1):54-7. PubMed ID: 26797839
[TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
23. Prognostic Value of Intraoperative Blood Transfusion in Patients with Adenocarcinoma of the Esophagogastric Junction.
Nakajima K; Tokunaga M; Okuno K; Saito K; Fujiwara N; Sato Y; Hoshino A; Matsuyama T; Kinugasa Y
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454312
[No Abstract] [Full Text] [Related]
24. Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction.
Cao J; Yang T; Wang G; Zhang H; You Y; Chen J; Yang J; Yang W
Surg Oncol; 2018 Sep; 27(3):556-562. PubMed ID: 30217319
[TBL] [Abstract][Full Text] [Related]
25. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
26. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.
Feng Y; Jiang Y; Zhao Q; Liu J; Zhang H; Chen Q
BMC Surg; 2020 Nov; 20(1):302. PubMed ID: 33256690
[TBL] [Abstract][Full Text] [Related]
28. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
30. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
[TBL] [Abstract][Full Text] [Related]
31. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
33. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
34. Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.
Zhang H; Shang X; Chen C; Gao Y; Xiao X; Tang P; Duan X; Yang M; Jiang H; Yu Z
Oncotarget; 2016 Nov; 7(45):74337-74349. PubMed ID: 27517157
[TBL] [Abstract][Full Text] [Related]
35. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
36. Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort).
Zhang JW; Huang L; Xu AM
Oncotarget; 2017 Aug; 8(34):57516-57527. PubMed ID: 28915691
[TBL] [Abstract][Full Text] [Related]
37. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
38. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients.
Hu K; Zheng QM; Wang YP; Zhao MM; Sun ZG
Eur J Cancer Prev; 2023 Mar; 32(2):119-125. PubMed ID: 36484275
[TBL] [Abstract][Full Text] [Related]
39. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary efficacy analysis of Cheng's Giraffe reconstruction after proximal gastrectomy in adenocarcinoma of esophagogastric junction].
Cheng XD; Xu ZY; Du YA; Hu C; Yu JF; Yang LT; Huang L; Yu PF; Dai GG; Zhang YQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):158-162. PubMed ID: 32074796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
